Cell Reports (Mar 2022)

Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense

  • Sonja Fernbach,
  • Eva E. Spieler,
  • Idoia Busnadiego,
  • Umut Karakus,
  • Anouk Lkharrazi,
  • Silke Stertz,
  • Benjamin G. Hale

Journal volume & issue
Vol. 38, no. 12
p. 110549

Abstract

Read online

Summary: Host interferons (IFNs) powerfully restrict viruses through the action of several hundred IFN-stimulated gene (ISG) products, many of which remain uncharacterized. Here, using RNAi screening, we identify several ISG restriction factors with previously undescribed contributions to IFN-mediated defense. Notably, RABGAP1L, a Tre2/Bub2/Cdc16 (TBC)-domain-containing protein involved in regulation of small membrane-bound GTPases, robustly potentiates IFN action against influenza A viruses (IAVs). Functional studies reveal that the catalytically active TBC domain of RABGAP1L promotes antiviral activity, and the RABGAP1L proximal interactome uncovered its association with proteins involved in endosomal sorting, maturation, and trafficking. In this regard, RABGAP1L overexpression is sufficient to disrupt endosomal function during IAV infection and restricts an early post-attachment, but pre-fusion, stage of IAV cell entry. Other RNA viruses that enter cells primarily via endocytosis are also impaired by RABGAP1L, while entry promiscuous SARS-CoV-2 is resistant. Our data highlight virus endocytosis as a key target for host defenses.

Keywords